Viewing nowCombinationRivaroxaban Tablets 4/160/10 mg (Pitavastatin Calcium Hydrate, Valsartan, Amlodipine Besylate)
Valsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Co., Ltd.

MFDS item code 202502532 · Approved 2025.09.24 · Insurance code 644915430
Treatment of hypercholesterolemia and mixed dyslipidemia, and essential hypertension
This medication is used for patients with essential hypertension where blood pressure is not well controlled with amlodipine and valsartan combination therapy and is prescribed only when pitavastatin is also required. Amlodipine and valsartan help effectively lower blood pressure, and pitavastatin improves cholesterol and triglyceride levels in patients with hypercholesterolemia and dyslipidemia. This contributes to cardiovascular health protection and prevention of complications.
Take 1 tablet once daily with water. It is recommended that the medicine be taken at the same time each day, if possible (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and pitavastatin. Patients taking the amlodipine/valsartan combination and pitavastatin as separate medicines may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination It is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted before administering the amlodipine/valsartan combination. However, a direct switch to the amlodipine/valsartan combination may be considered if blood pressure is not controlled with monotherapy using either component, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients with renal impairment: No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater). Do not administer the amlodipine/valsartan combination to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan must not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years and older: Use caution when increasing the dose. ▷ Pitavastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient's response. The therapeutic effect of this medicine is maintained with continued administration.
This drug may cause serious harm to the fetus and newborn in the second and third trimesters of pregnancy; therefore, women who are pregnant or may become pregnant should not take it. Patients with allergies to any component in this medication, severe liver disease, kidney disease, or certain heart diseases should not take this drug. Patients with conditions like hypotension, hyperkalemia, or renal artery stenosis must consult their doctor before taking this medication, and periodically check blood pressure and potassium levels while on this medication. During treatment, symptoms such as myalgia, weakness, jaundice, and rash may occur, and patients should inform healthcare providers immediately if these symptoms appear. Caution is advised when driving or operating machinery, as dizziness or fatigue may occur, particularly in the elderly, starting with a low dose and gradually increasing is recommended for safety. Interactions may occur with other medications, so patients should inform healthcare providers of any other medications being taken. Pregnant or breastfeeding women should not use this medication; breastfeeding should be discontinued if taking this drug. Safety and efficacy for children have not been established; therefore, it should not be used in patients under 18 years of age. In cases of overdose, severe hypotension or cardiac problems may occur; patients should adhere strictly to dosing and seek immediate medical attention in case of overdose. This medication should be stored out of reach of children, and kept in its original container to prevent misuse or quality degradation.
COVID-19, nasopharyngitis, systemic edema, peripheral edema, elevated serum creatine kinase levels, headache, pruritus, sudden hearing loss, intestinal obstruction, diplopia, thrombocytopenia, leukopenia, allergic reactions, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disturbance, peripheral neuropathy, muscle hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reactions, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturia, gynecomastia, pain, lethargy, chest pain, weight loss, weight gain, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, serum sickness, increased serum potassium, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, intestinal vascular edema, abdominal pain, rash, paralysis, elevated γ-GT, increased plasma creatine phosphokinase levels, elevated serum ALT, elevated serum AST, rhabdomyolysis, myopathy, liver dysfunction, jaundice, thrombocytopenia, urticaria, rash, erythema, angioedema, elevated bilirubin, increased cholinesterase, elevated AST, elevated ALT, elevated γ-GT, elevated ALP, elevated LDH, rigidity, drowsiness, headache, heaviness in the head, paralysis, dizziness, dry mouth, dyspepsia, abdominal pain, abdominal distension, constipation, stomatitis, vomiting, loss of appetite, glossitis, nausea, gastrointestinal discomfort, diarrhea, thrombocytopenia, decreased granulocyte count, leukopenia, increased eosinophil count, leukocytosis, increased globulins, positive Coombs test, anemia, increased urinary frequency, elevated BUN, elevated serum creatinine, decreased aldosterone, increased aldosterone, increased ACTH, increased cortisol, decreased testosterone, muscle cramps, increased serum myoglobin, elevated CPK, muscle pain, weakness, palpitations, fatigue, skin pain, burning sensation, arthralgia, edema, blurred vision, photophobia, hearing loss, urinary hematuria, elevated uric acid levels, increased serum potassium and phosphorus, taste disturbance, colored urine, generalized lethargy, positive ANA, alopecia, sleep disorders, memory loss, depression, interstitial lung disease, sexual dysfunction, immune-mediated necrotizing myopathy, elevated blood pressure, skin paresthesia, chest discomfort, facial edema, arm edema, hypersensitivity, dizziness, skin paresthesia, loss of appetite, weakness
Not everyone experiences these, and they can vary from person to person.
This medication should be stored at room temperature between 1°C and 30°C, ensuring it is kept in a tightly sealed container to prevent air exposure. Proper storage will maintain the effectiveness of the medication.
Dark pink oval film-coated tablet
30 tablets/PTP [6 tablets/PTP x 5]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.